The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.
Cross-Sectional
Study Type
OBSERVATIONAL
Enrollment
100
Dermatology Hospital of Southern Medical University /ID# 276921
Guangzhou, Guangdong, China
Wuhan Integrated TCM & Western Medicine Hospital(Wuhan No.1 Hospital) /ID# 276919
Wuhan, Hubei, China
Suzhou Municipal Hospital /ID# 276948
Suzhou, Jiangsu, China
Shandong Dermatological Hospital /ID# 276918
Jinan, Shandong, China
Total Vitiligo Area Scoring Index (T-VASI)
The T-VASI is calculated using a formula that includes contributions from all body regions, with a possible range from 0 to 100, with higher scores indicating more severe disease.
Time frame: At Inclusion Visit (Day 1)
Vitiligo Quality of Life Scale (VitiQoL)
The VitiQoL is an 16-item instrument assessing impact of vitiligo on quality of life. 15 items are scored on a 7-point Likert scale, ranging from "not at all" to "all the time". An additional item (not contributing to total score) assesses current severity of condition on a 7-point scale ranging from "no skin involvement" to "most severe case"
Time frame: At Inclusion Visit (Day 1)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.